NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 286 participants.
Also called NCT06141200
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 286 participants
- Sponsor
- Natural Wellness Egypt
- Registry
-
NCT06141200
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06141200. Randomized; quadruple masking; primary purpose treatment. Start 2024-03 (anticipated); primary completion 2025-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial
- Condition
- Essential Hypertension
- Intervention (Drug)
- NW Roselle
- Intervention (Drug)
- Captopril 25Mg Tab
- Lead sponsor
- Natural Wellness Egypt
Record details
- Record id
cardio:ct-nct06141200- Content hash
b18c7e15fb7ca14db85e29faeced80f0d820689583af87f8d831d9f8a4711c0b